Comparing the cost-effectiveness of perioperative immunotherapy strategies in non-small cell lung cancer

被引:0
|
作者
Muthusamy, B. [1 ]
Zabor, E. C. [2 ]
Pennell, N. A. [1 ]
机构
[1] Cleveland Clin, Hematol & Med Oncol, Taussig Canc Ctr, Cleveland, OH USA
[2] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH USA
关键词
D O I
10.1016/j.annonc.2023.09.765
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1287P
引用
收藏
页码:S743 / S743
页数:1
相关论文
共 50 条
  • [41] Immunotherapy for Non-Small Cell Lung Cancer
    Yoon, Sung Ho
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (03) : 111 - 115
  • [42] Immunotherapy in non-small cell lung cancer
    Peters, Geoffrey
    John, Thomas
    [J]. CANCER FORUM, 2018, 42 (01) : 24 - 28
  • [43] Immunotherapy for non-small cell lung cancer
    Kagamu, Hiroshi
    [J]. RESPIRATORY INVESTIGATION, 2024, 62 (02) : 307 - 312
  • [44] Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach
    Hui, Wen
    Song, Ruomeng
    Tao, Hongyu
    Gao, Zhixiang
    Zhu, Min
    Zhang, Mingyue
    Wu, Huazhang
    Gong, Daichen
    Zhang, Xiyan
    Cai, Yuanyi
    [J]. BMC CANCER, 2023, 23 (01)
  • [45] Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach
    Bullement, Ash
    Edmondson-Jones, Mark
    Latimer, Nicholas
    [J]. BMC CANCER, 2024, 24 (01)
  • [46] Perioperative Outcomes and Survival After Preoperative Immunotherapy for Non-Small Cell Lung Cancer
    Mayne, Nicholas R.
    Potter, Alexandra L.
    Bharol, Kashika
    Darling, Alice J.
    Raman, Vignesh
    Cao, Christopher
    Li, Xiao
    D'Amico, Thomas A.
    Yang, Chi-Fu Jeffrey
    [J]. ANNALS OF THORACIC SURGERY, 2022, 113 (06): : 1811 - 1820
  • [47] Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
    Qiu, Bin
    Cai, Kaican
    Chen, Chun
    Chen, Jun
    Chen, Ke-Neng
    Chen, Qi-Xun
    Cheng, Chao
    Dai, Tian-Yang
    Fan, Junqiang
    Fan, Zhaohui
    Hu, Jian
    Hu, Wei-Dong
    Huang, Yun-Chao
    Jiang, Ge-Ning
    Jiang, Jie
    Jiang, Tao
    Jiao, Wen-Jie
    Li, He-Cheng
    Li, Qiang
    Liao, Yong-De
    Liu, Hong-Xu
    Liu, Jun-Feng
    Liu, Lunxu
    Liu, Yang
    Long, Hao
    Luo, Qing-Quan
    Ma, Hai-Tao
    Mao, Nai-Quan
    Pan, Xiao-Jie
    Tan, Fengwei
    Tan, Li-Jie
    Tian, Hui
    Wang, Dong
    Wang, Wen-Xiang
    Wei, Li
    Wu, Nan
    Wu, Qing-Chen
    Xiang, Jiaqing
    Xu, Shi-Dong
    Yang, Lin
    Zhang, Hao
    Zhang, Lanjun
    Zhang, Peng
    Zhang, Yi
    Zhang, Zhenfa
    Zhu, Kunshou
    Zhu, Yuming
    Um, Sang-Won
    Oh, In-Jae
    Tomita, Yusuke
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (09) : 3713 - 3736
  • [48] Perioperative immunotherapy: the main clinical treatment for resectable non-small cell lung cancer
    Yuan, Zhijun
    Yang, Mengyuan
    Zhong, Xian
    [J]. MEDCOMM, 2024, 5 (03):
  • [49] Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
    Lim, Jeong Uk
    Kang, Hye Seon
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (09) : 3709 - 3712
  • [50] Immunotherapy combination strategies (non-chemotherapy) in non-small cell lung cancer
    Niyongere, Sandrine
    Saltos, Andreas
    Gray, Jhanelle E.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S433 - S450